Skip to content
Medical Health Aged Care

RACGP lauds introduction of needle-free flu vaccines in Queensland

Royal Australian College of GPs 2 mins read

The Royal Australian College of GPs (RACGP) has applauded the Queensland Government’s announcement of no-cost needle-free influenza vaccinations for children aged 2–5 ahead of the 2026 flu season.

RACGP Queensland Chair Dr Cathryn Hester praised the initiative as a major step forward in public health.

“Needle-free vaccine access, at no cost to families, will save lives and save families the terrifying experience of having your young child in hospital,” Dr Hester said.

“These needle-free vaccines have been tested extensively overseas. They’ve been shown to be safe and effective, and they mean parents and young children’s experience of vaccination isn’t a needle, just a quick spray.

“It’ll be a revolution for Queensland families.  This means no-tears protection from severe flu, at no cost.

“Vaccination is the best way to stop the flu from spreading in the community. The more people, especially the young, who can receive vaccination, the more we can prevent serious illness or hospitalisation.”

The new program will provide free needle-free flu vaccines to children aged 2–5 years, a move Dr Hester says will ease the concerns of many parents and carers.

“Funding access to this new vaccine will help relieve the stress many parents feel when it comes to giving small children an injection,” she said.

“Around two thirds of parents say they feel distressed about vaccinating their child against influenza, and that’s true among both those who intend to vaccinate and those who do not. Needles are a huge barrier – about a quarter of us have a strong fear of needles.

“This breaks that barrier. That matters because young kids are particularly vulnerable to the severe effects of the flu.

“A needle-free option will reduce anxiety for those who are needle-averse and help boost vaccination rates.”

Dr Hester also highlighted the broader impact of increased flu vaccination coverage.

“Stopping the spread of these viruses and boosting vaccination rates, including for the flu, relieves pressure on our entire healthcare system, including our hospitals,” she said.

The past two years are among the worst years on record for flu cases in Queensland and Australia. So far in 2025, there have been 74,892 lab-confirmed influenza cases in Queensland, and 362,860 nationwide.

In 2024, which had the most cases on record even when adjusted for population, Queensland had 79,798 influenza cases, and Australia 365,590 – meaning by the end of the year, 2025 may be a record for Queensland and Australia.

“With new cases still evident, it is almost certain Australia will have more flu cases than previous years, potentially making 2025 a new record year for the number of lab-confirmed flu cases,” Dr Hester said.

Deaths from influenza from 1 January–31 July 2025 are also significant, both in Queensland (94) and, Australia (470).

Earlier this year, the RACGP urged Australians to protect themselves and others against influenza, warning of rising case numbers and hospitalisations during the peak winter months.

The RACGP is calling on other states to follow suit in making flu vaccination more accessible and less stressful for families.

~ENDS


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Senior Media Advisor

Stuart Winthrope
Media Advisor

Kevin Diggerson
Public Affairs Manager

Contact: 03 8699 0992[email protected]

Follow us on X and Facebook.

Media

More from this category

  • Indigenous, Medical Health Aged Care
  • 26/03/2026
  • 10:00
Charles Darwin University

CDU EXPERT: Fuel crisis causing inequitable access to health care and food security

26MARCH,2026 Who:ProfessorofIndigenous HealthYvette Roe,Directorof theMollyWardagugaInstitute for First Nations Birth RightsatCharles DarwinUniversity. Topics: Rising fuel prices and the impact this will have on food security and the health and well-being of mums and bubs Food security Contact details:Call +61 8 8946 6721 or email [email protected] to arrange an interview. Quotes attributable toProfessorYvette Roe: “Aboriginal women and girls in this in our remote Territory communities experience some of the poorest sexual, reproductive, maternal, infant, and child health outcomes in Australia (e.g. preterm birth rates are regularly the highest in the country at 18-22%). Acute poverty, overcrowding, limited employment opportunity and food security are keysocio-economic determinants for a thriving mother and babyduringacross the lifecourse. “Mums andbabies whorequireregular check-ups, antenatal care, and access to nutritious food and prenatal vitamins are most at risk…

  • Government Federal, Medical Health Aged Care
  • 26/03/2026
  • 06:10
Australian College of Nursing

Let nurse practitioners lead Urgent Care Clinics to address staffing issues

The Australian College of Nursing is calling on the Federal Government to revise guidelines to allow nurse practitioners to lead care independently in Medicare Urgent Care Clinics (UCCs), with GP recruitment an ongoing challenge for the program. Nurse practitioners are among the most highly qualified clinicians in our health system, capable of leading UCCs, but the current Medicare Urgent Care Clinic Program Operational Guidance mandates that clinics will be GP-led, with a vocationally registered general practitioner required at a minimum. The latest evaluation of the program noted recruitment of appropriately qualified doctors remains an issue, and that Medicare Benefits Schedule…

  • Contains:
  • Medical Health Aged Care
  • 26/03/2026
  • 06:00
Monash University

New medicine piggybacks onto fat absorption pathways to allow oral delivery and support clinical trial in major depressive disorder

Monash University and Seaport Therapeutics have developed a new approach to delivering drug molecules that piggybacks onto natural fat absorption pathways to allow oral delivery of some drugs previously requiring injection. The research, published today inScience Translational Medicine, describes the first clinical evidence that a fat, or lipid, modified version of the naturally occurring neurosteroid allopregnanolone (GlyphAllo™) can result in high enough levels of the substance in the human bloodstream to be potentially effective. The endogenous neurosteroid allopregnanolone is a well-established molecule known for its clinically validated antidepressant, anti-anxiety and sleep-promoting effects – but to this point had to be…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.